The Future of Aseptic Manufacturing: Compact and Advanced Solutions
As the pharmaceutical industry advances into more complex modalities, from biologics to cell and gene therapies, the need for flexible,...
Dr. Dave Seaward : 20 January 2022
PDF File: Cell and Gene Therapy: Converting a Rolls-Royce into a Ford?
With promising applications in the personalised medicines field, Cell and Gene Therapies are becoming more and more relevant. This, alongside 3Ps experience in the manufacturing of said therapies, has inspired 3P Founder and Projects Director Dave Seaward, to write a new blog series all about ATMPs!
Click the pdf link above and take a read of the first blog in the series.
This first blog focuses around the manufacture of cell and gene therapies with an interesting analogy to the automotive industry. It also looks at how 3P innovation can help with the manufacture of these life-changing ATMPs.
As the pharmaceutical industry advances into more complex modalities, from biologics to cell and gene therapies, the need for flexible,...
In this webinar recap, David Johnson, Sales & Marketing Director at 3P innovation, and Tracy Moore, Principal Consultant at TM Pharma and former...
Our DPI blister filling capabilities draw on long-standing experience, our founder, Tom Bailey, is one of the named inventors of the DPI filling...